Impulse control and repetitive behaviors in Parkinson's disease - Are there differences in the relation to dopamine agonist treatment?

被引：0
|
作者：
Hatteland Somme, Johanne [1 ,2 ]
Carlos Gomez-Esteban, Juan [1 ]
Tijero, Beatriz [1 ]
Berganzo, Koldo [1 ]
Lezcano, Elena [1 ]
Jose Zarranz, Juan [1 ]
机构：
[1] Univ Basque Country, Movement Disorders Unit, Serv Vasco Salud Osakidetza, Dept Neurol,Cruces Univ Hosp,Dept Neurosci, Bilbao, Spain
[2] Alava Univ Hosp, Dept Neurol, Serv Vasco Salud Osakidetza, Vitoria, Spain
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2014年 / 345卷 / 1-2期
关键词：
Parkinson's disease; Impulse control disorders; Dopamine agonists; Levodopa; Neuropsychiatry; Punding; CONTROL DISORDERS; ROTIGOTINE;
D O I：
10.1016/j.jns.2014.07.004
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：252 / 253
页数：2
相关论文
共 50 条
  • [21] Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
    Garcia-Ruiz, Pedro J.
    Martinez Castrillo, Juan Carlos
    Alonso-Canovas, Araceli
    Herranz Barcenas, Antonio
    Vela, Lydia
    Sanchez Alonso, Pilar
    Mata, Marina
    Olmedilla Gonzalez, Nuria
    Mahillo Fernandez, Ignacio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (08): : 841 - 845
  • [22] Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: A multicenter study
    Garcia Ruiz, P. J.
    Martinez Castrillo, J. C.
    Alonso Canovas, A.
    Herranz Barcenas, A.
    Vela Desojo, L.
    Sanchez Alonso, P.
    Mata, M.
    Olmedilla Gonzalez, N.
    Mahillo Fernandez, I.
    MOVEMENT DISORDERS, 2014, 29 : S139 - S140
  • [23] Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease
    Ahlskog, J. Eric
    PHYSIOLOGY & BEHAVIOR, 2011, 104 (01) : 168 - 172
  • [24] Dopamine agonists and impulse control disorders in Parkinson's disease
    MacMahon, Douglas G.
    Macphee, Graeme J. A.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2008, 12 (09) : 5 - +
  • [25] Impulse control and related behaviors in Parkinson's disease with dementia
    Martinez-Martin, P.
    Wan, Y. M.
    Ray Chaudhuri, K.
    Schrag, A. E.
    Weintraub, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (06) : 944 - 950
  • [26] Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease
    Bennett, JP
    Piercey, MF
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) : 25 - 31
  • [27] Treatment of Parkinson's disease should begin with a dopamine agonist
    Montastruc, JL
    MOVEMENT DISORDERS, 2000, 15 (02) : 361 - 362
  • [28] Should treatment of Parkinson's disease be started with a dopamine agonist?
    Poewe, W
    NEUROLOGY, 1998, 51 (02) : S21 - S24
  • [29] A novel dopamine agonist for the transdermal treatment of Parkinson's disease
    Jenner, P
    NEUROLOGY, 2005, 65 (02) : S3 - S5
  • [30] Treatment of Parkinson's disease should begin with a dopamine agonist
    Montastruc, JL
    Rascol, O
    Senard, JM
    MOVEMENT DISORDERS, 1999, 14 (05) : 725 - 730
12345